Analysis of safety and outcome of use of NOAC in intracardiac thrombi over warfarin

Back

ESC Professional Premium Access

Analysis of safety and outcome of use of NOAC in intracardiac thrombi over warfarin

Session: Clinical and experimental arrhythmia treatments

Topic: Treatment

Speaker: Doctor O. Al-assaf (Dubai, AE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Omar Al-assaf

Rashid Hospital, Dubai (United Arab Emirates)

0 follower

8 more presentations in this session

Efficacy and safety of ultrasound guided stellate ganglion block: developing new clinical indications beyond electrical storm

Speaker: Doctor A. Morena (Turin, IT)

Atrial and ventricular arrhythmias in young, lifelong and retired elite endurance athletes

Speaker: Doctor P. D'Ambrosio (Fitzroy, AU)

Amiodarone-related thyroid dysfunction and associated outcomes in patients with heart failure - a matched case-control study

Speaker: Doctor S. Ali (Copenhagen, DK)

Association between preprocedural thromboembolic or bleeding events under oral anticoagulation therapy and mid-term outcomes after percutaneous left atrial appendage closure

Speaker: Doctor H. Sumiyoshi (Kurashiki, JP)

BA6b9, a novel sk4 K + channel blocker, attenuates atrial fibrillation substrate in rats with reduced ejection fraction

Speaker: Mr O. Levi (IL)

Access the full session

Clinical and experimental arrhythmia treatments

Speakers: Doctor O. Al-assaf, Doctor A. Morena, Doctor P. D'Ambrosio, Doctor S. Ali, Doctor H. Sumiyoshi...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources